Frostyyy
2021-11-02
Go go go!!!
Novavax shares jumped another 4.4% in premarket trading<blockquote>Novavax 股价在盘前交易中又上涨 4.4%</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
8
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":843581898,"tweetId":"843581898","gmtCreate":1635841643487,"gmtModify":1635841646978,"author":{"id":3581131361771943,"idStr":"3581131361771943","authorId":3581131361771943,"authorIdStr":"3581131361771943","name":"Frostyyy","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>Go go go!!! </p></body></html>","htmlText":"<html><head></head><body><p>Go go go!!! </p></body></html>","text":"Go go go!!!","highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/843581898","repostId":1146954113,"repostType":2,"repost":{"id":"1146954113","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635841327,"share":"https://www.laohu8.com/m/news/1146954113?lang=zh_CN&edition=full","pubTime":"2021-11-02 16:22","market":"us","language":"en","title":"Novavax shares jumped another 4.4% in premarket trading<blockquote>Novavax 股价在盘前交易中又上涨 4.4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1146954113","media":"Tiger Newspress","summary":"Novavax shares jumped another 4.4% in premarket trading Tuesday after rising nearly 16% yesterday as","content":"<p>Novavax shares jumped another 4.4% in premarket trading Tuesday after rising nearly 16% yesterday as Novavax COVID-19 vaccine got first authorization; expected more within weeks.</p><p><blockquote>随着 Novavax COVID-19 疫苗首次获得授权，Novavax 股价继昨天上涨近 16% 后，周二盘前交易中又上涨 4.4%；预计几周内会有更多。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/93777ff8ed669db1e3ea1516ae6b0f1f\" tg-width=\"849\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.</p><p><blockquote>诺瓦瓦克斯公司首席执行官告诉路透社，该公司预计印度、菲律宾和其他地方的监管机构将在 “几周内 ”内就其 COVID-19 疫苗做出决定。</blockquote></p><p> The company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.</p><p><blockquote>该公司还表示，已向加拿大和欧洲药品管理局提交了紧急使用该疫苗的申请。</blockquote></p><p> For Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.</p><p><blockquote>对于印度尼西亚来说，这种疫苗将由世界上最大的疫苗制造商印度血清研究所（SII）生产，并以印度公司 Covovax 的品牌名称销售。Novavax 表示，预计即将开始向印度尼西亚发货。</blockquote></p><p> The World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.</p><p><blockquote>世界卫生组织（WHO）首席执行官斯坦利-埃克（Stanley Erck）周一在接受路透社电话采访时表示，世界卫生组织（WHO）也在审查 Novavax 的监管文件，这家美国制药商预计审查将在未来几周内得到解决。</blockquote></p><p> A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.</p><p><blockquote>世卫组织的绿灯将为 Novavax 开始向 COVAX 计划运送疫苗奠定基础，该计划为低收入国家提供疫苗。Novavax 和 SII 共同承诺向世卫组织共同领导的 COVAX 提供超过 11 亿剂疫苗。</blockquote></p><p> “I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.</p><p><blockquote>“埃尔克说：”我认为我们今年会给 COVAX 提供一些剂量。“但我认为（Novavax）将在2022年第一季度真正开始能够向COVAX运送大量物资”。</blockquote></p><p> Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.</p><p><blockquote>Erck表示，Novavax已经解决了所有制造挑战，预计监管机构不会对其生产流程有任何进一步的担忧。</blockquote></p><p> He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”</p><p><blockquote>他说，Novavax 正在 “与美国食品及药物管理局进行对话......我们预计将在未来几周内提交完整的材料”。</blockquote></p><p> Novavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.</p><p><blockquote>Novavax 已推迟提交美国批准申请，Politico 上个月报道称，该公司面临生产和质量问题。</blockquote></p><p> SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.</p><p><blockquote>SII 被授权生产 Novavax 疫苗，这家美国公司表示将在未来几周内为其他工厂申请监管部门授权，例如其在捷克共和国的工厂。</blockquote></p><p> Indonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.</p><p><blockquote>据印度尼西亚政府称，印度尼西亚今年将收到 2000 万剂基于蛋白质的疫苗。</blockquote></p><p> Penny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.</p><p><blockquote>印度尼西亚国家药品和食品控制局局长彭妮·卢基托没有立即回应路透社的置评请求。</blockquote></p><p> Novavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.</p><p><blockquote>迄今为止，Novavax已在英国、澳大利亚、印度和菲律宾等多个国家申请EUA。</blockquote></p><p> “It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.</p><p><blockquote>埃尔克说：“他们需要几周时间，而不是几个月的时间来审查 ”Novavax 提交的监管文件，并有可能批准使用疫苗。</blockquote></p><p> The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.</p><p><blockquote>该公司及其日本合作伙伴武田制药公司周五表示，正准备寻求监管部门批准明年初在日本推出该产品。</blockquote></p><p> The Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.</p><p><blockquote>Novavax注射被证明有90%以上的有效性，包括在美国的一项大型后期试验中针对各种令人担忧的冠状病毒变种。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares jumped another 4.4% in premarket trading<blockquote>Novavax 股价在盘前交易中又上涨 4.4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares jumped another 4.4% in premarket trading<blockquote>Novavax 股价在盘前交易中又上涨 4.4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-02 16:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares jumped another 4.4% in premarket trading Tuesday after rising nearly 16% yesterday as Novavax COVID-19 vaccine got first authorization; expected more within weeks.</p><p><blockquote>随着 Novavax COVID-19 疫苗首次获得授权，Novavax 股价继昨天上涨近 16% 后，周二盘前交易中又上涨 4.4%；预计几周内会有更多。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/93777ff8ed669db1e3ea1516ae6b0f1f\" tg-width=\"849\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.</p><p><blockquote>诺瓦瓦克斯公司首席执行官告诉路透社，该公司预计印度、菲律宾和其他地方的监管机构将在 “几周内 ”内就其 COVID-19 疫苗做出决定。</blockquote></p><p> The company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.</p><p><blockquote>该公司还表示，已向加拿大和欧洲药品管理局提交了紧急使用该疫苗的申请。</blockquote></p><p> For Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.</p><p><blockquote>对于印度尼西亚来说，这种疫苗将由世界上最大的疫苗制造商印度血清研究所（SII）生产，并以印度公司 Covovax 的品牌名称销售。Novavax 表示，预计即将开始向印度尼西亚发货。</blockquote></p><p> The World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.</p><p><blockquote>世界卫生组织（WHO）首席执行官斯坦利-埃克（Stanley Erck）周一在接受路透社电话采访时表示，世界卫生组织（WHO）也在审查 Novavax 的监管文件，这家美国制药商预计审查将在未来几周内得到解决。</blockquote></p><p> A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.</p><p><blockquote>世卫组织的绿灯将为 Novavax 开始向 COVAX 计划运送疫苗奠定基础，该计划为低收入国家提供疫苗。Novavax 和 SII 共同承诺向世卫组织共同领导的 COVAX 提供超过 11 亿剂疫苗。</blockquote></p><p> “I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.</p><p><blockquote>“埃尔克说：”我认为我们今年会给 COVAX 提供一些剂量。“但我认为（Novavax）将在2022年第一季度真正开始能够向COVAX运送大量物资”。</blockquote></p><p> Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.</p><p><blockquote>Erck表示，Novavax已经解决了所有制造挑战，预计监管机构不会对其生产流程有任何进一步的担忧。</blockquote></p><p> He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”</p><p><blockquote>他说，Novavax 正在 “与美国食品及药物管理局进行对话......我们预计将在未来几周内提交完整的材料”。</blockquote></p><p> Novavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.</p><p><blockquote>Novavax 已推迟提交美国批准申请，Politico 上个月报道称，该公司面临生产和质量问题。</blockquote></p><p> SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.</p><p><blockquote>SII 被授权生产 Novavax 疫苗，这家美国公司表示将在未来几周内为其他工厂申请监管部门授权，例如其在捷克共和国的工厂。</blockquote></p><p> Indonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.</p><p><blockquote>据印度尼西亚政府称，印度尼西亚今年将收到 2000 万剂基于蛋白质的疫苗。</blockquote></p><p> Penny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.</p><p><blockquote>印度尼西亚国家药品和食品控制局局长彭妮·卢基托没有立即回应路透社的置评请求。</blockquote></p><p> Novavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.</p><p><blockquote>迄今为止，Novavax已在英国、澳大利亚、印度和菲律宾等多个国家申请EUA。</blockquote></p><p> “It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.</p><p><blockquote>埃尔克说：“他们需要几周时间，而不是几个月的时间来审查 ”Novavax 提交的监管文件，并有可能批准使用疫苗。</blockquote></p><p> The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.</p><p><blockquote>该公司及其日本合作伙伴武田制药公司周五表示，正准备寻求监管部门批准明年初在日本推出该产品。</blockquote></p><p> The Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.</p><p><blockquote>Novavax注射被证明有90%以上的有效性，包括在美国的一项大型后期试验中针对各种令人担忧的冠状病毒变种。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146954113","content_text":"Novavax shares jumped another 4.4% in premarket trading Tuesday after rising nearly 16% yesterday as Novavax COVID-19 vaccine got first authorization; expected more within weeks.\n\nNovavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.\nThe company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.\nFor Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.\nThe World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.\nA green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.\n“I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.\nErck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.\nHe said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”\nNovavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.\nSII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.\nIndonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.\nPenny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.\nNovavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.\n“It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.\nThe company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.\nThe Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3019,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":9,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/843581898"}
精彩评论